Second trimester amniocentesis in twin pregnancies: maternal haemoglobin as a dye marker to differentiate diamniotic twins
- 1 February 1992
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 99 (2) , 126-127
- https://doi.org/10.1111/j.1471-0528.1992.tb14469.x
Abstract
To review the use of a membrane-free haemolysate prepared from maternal blood to distinguish the amniotic sacs at amniocentesis in twin gestation. University Hospital, Groningen. Haemoglobin solution prepared from maternal blood. 63 twin pregnancies having amniocentesis. The fetal loss before 28 weeks was 4%. There was no perinatal mortality. Dye was detected in the second sac in 9 of 24 women tested before 1985 and none of the 39 women since, no malformations could be ascribed to the use of the haemolysate. The use of the membrane-free haemolysate is safe, but the technique will probably gradually become redundant because of improved ultrasound.Keywords
This publication has 12 references indexed in Scilit:
- Intestinal obstruction in babies exposed in utero to methylene blueThe Lancet, 1990
- Genetic amniocentesis in twin pregnanciesBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Biamnial elevated alpha-fetoprotein and positive acetylcholinesterase in twins, one with anencephalyPrenatal Diagnosis, 1987
- Genetic amniocentesis in multiple gestationsPrenatal Diagnosis, 1984
- Genetic amniocentesis in seventy twin pregnanciesAmerican Journal of Obstetrics and Gynecology, 1984
- Genetic amniocentesis in twin pregnancyPrenatal Diagnosis, 1983
- Increased risk of abortion after genetic amniocentesis in twin pregnanciesPrenatal Diagnosis, 1983
- Genetic amniocentesis in twin gestationsAmerican Journal of Obstetrics and Gynecology, 1980
- Twin Pregnancy with Discordancy for Downʼs SyndromeObstetrics & Gynecology, 1980
- Danger in the Use of Intrathecal Methylene BluePublished by American Medical Association (AMA) ,1960